Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Response to phytohemagglutinin of LL patients' lymphocytes preincubated in culture media.

Fafutis-Morris M, Alfaro-Bustamante F, Gonzalez-Mendoza A, Morales-Ortiz R, Islas-Rodriguez AE.

Int J Lepr Other Mycobact Dis. 1991 Sep;59(3):480-2. No abstract available.

PMID:
1890372
2.

Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy.

Alfaro-Bustamante F, Ramirez-Flores G, Gonzalez-Mendoza A, Islas-Rodriguez A, Fafutis-Morris M.

Int J Lepr Other Mycobact Dis. 1997 Mar;65(1):73-9.

PMID:
9207756
3.

Reduced suppressor cell response to Mycobacterium leprae in lepromatous leprosy.

Sasiain MD, de la Barrera S, Valdez R, Balina LM.

Infect Immun. 1989 Mar;57(3):951-6.

4.

Alterations in early biochemical events following T cell activation in leprosy patients.

Sharma N, Sharma VK, Gupta A, Kaur I, Kaur S, Ganguly NK.

Clin Immunol Immunopathol. 1998 Aug;88(2):142-9.

PMID:
9714691
5.
6.

Intradermal recombinant interleukin 2 enhances peripheral blood T-cell responses to mitogen and antigens in patients with lepromatous leprosy.

Converse P, Ottenhoff TH, Work Teklemariam S, Hancock GE, Dietz M, Becx-Bleumink M, Wondimu A, Kiessling R, Cohn ZA, Kaplan G.

Scand J Immunol. 1990 Aug;32(2):83-91.

PMID:
2389115
7.

Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.

Shinde SR, Chiplunkar SV, Butlin R, Samson PD, Deo MG, Gangal SG.

Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):51-8.

PMID:
8326181
8.
10.

CD2 expression and function in lepromatous leprosy.

Wong L, Salgame P, Torigian VK, Fu TH, Rea TH, Modlin RL.

Infect Immun. 1989 Sep;57(9):2815-9.

11.

Blastogenic response with autologous plasma and Mitsuda's reaction in leprosy patients and their unaffected sibs.

Foss NT, Pagnano PM, Bechelli LM, Lima Filho EC.

Acta Leprol. 1991;7(4):335-45.

PMID:
1950443
12.

T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.

Launois P, Huygen K, De Bruyn J, N'Diaye M, Diouf B, Sarthouj L, Grimaud J, Millan J.

Clin Exp Immunol. 1991 Nov;86(2):286-90.

13.

Mycobacterium leprae reactive T cell clones from lepromatous leprosy patients after prolonged dapsone chemotherapy.

Gill HK, Ridley DS, Ganesan J, Mustafa AS, Rees RJ, Godal T.

Lepr Rev. 1990 Mar;61(1):25-31.

PMID:
2181222
15.

Lepromatous and tuberculoid leprosy: clinical presentation and cytokine responses.

Ochoa MT, Valderrama L, Ochoa A, Zea A, Escobar CE, Moreno LH, Falabella R.

Int J Dermatol. 1996 Nov;35(11):786-90.

PMID:
8915730
16.

ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum.

Sasiain MC, Ruibal Ares B, Baliña LM, Valdez R, Bachmann AE.

Int J Lepr Other Mycobact Dis. 1983 Sep;51(3):321-7.

PMID:
6227570
18.

Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy.

Makonkawkeyoon S, Kasinrerk W, Dettrairat S, Vithayasai V.

Int J Lepr Other Mycobact Dis. 1990 Jun;58(2):302-10.

PMID:
2142947
19.

Evidence of cell-mediated immune contrasuppression in lepromatous leprosy: modulation of a putative T contrasuppressor cell-subset.

González-Amaro R, Salazar-González JF, Baranda L, Abud-Mendoza C, Moncada B, García R, Alcocer-Varela J.

Clin Exp Immunol. 1988 Mar;71(3):399-404.

20.

A role for IL-12 receptor expression and signal transduction in host defense in leprosy.

Kim J, Uyemura K, Van Dyke MK, Legaspi AJ, Rea TH, Shuai K, Modlin RL.

J Immunol. 2001 Jul 15;167(2):779-86.

Supplemental Content

Support Center